stockcue

REGN (Regeneron Pharmaceuticals, Inc.): Stockcue Score 73/100 — Solid profile · Valuation 66/100 · Financial health 95/100 · Growth 57/100 · price $803.48. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s